A review on the antimicrobial assessment of triazole-azomethine functionalized frameworks incorporating transition metals
Antimicrobial resistance is a growing threat to global public health that calls for innovative
strategies to develop new methods of action against resistance to emerging infectious …
strategies to develop new methods of action against resistance to emerging infectious …
Schiff base metal complexes as anti-inflammatory agents
Schiff bases (SB) have unique potential to bind metal ions for widespread applications,
especially in the pharmacological industry. The condensation of primary imine and carbonyl …
especially in the pharmacological industry. The condensation of primary imine and carbonyl …
Cobalt (II), nickel (II), copper (II) and zinc (II) complexes of thiadiazole based Schiff base ligands: Synthesis, structural characterization, DFT, antidiabetic and molecular …
A new series of transition metal complexes of type [M (L 1-3)(H 2 O)(CH 3 COO)] where, M=
Co (II), Ni (II), Cu (II) & Zn (II), and L 1= 2-(((1, 3, 4-thiadiazol-2-yl) imino) methyl)-6 …
Co (II), Ni (II), Cu (II) & Zn (II), and L 1= 2-(((1, 3, 4-thiadiazol-2-yl) imino) methyl)-6 …
Synthesis, structure elucidation, antioxidant, antimicrobial, anti-inflammatory and molecular docking studies of transition metal (II) complexes derived from heterocyclic …
In the search of significant biological agents for the pathogenic causing deformities, four
bidentate heterocyclic Schiff base ligands and their sixteen Co (II), Ni (II), Cu (II) and Zn (II) …
bidentate heterocyclic Schiff base ligands and their sixteen Co (II), Ni (II), Cu (II) and Zn (II) …
Synthesis, characterization, pharmacological screening, molecular docking, DFT, MESP, ADMET studies of transition metal (II) chelates of bidentate schiff base ligand
The death causing infectious diseases are increased very rapidly, therefore, to find out a
significant agent for these ailments, a family of four transition metal complexes were …
significant agent for these ailments, a family of four transition metal complexes were …
Synthesis, structural analysis, in vitro antioxidant, antimicrobial activity and molecular docking studies of transition metal complexes derived from Schiff base ligands of …
Abstract Sixteen Co (II), Ni (II), Cu (II) and Zn (II) complexes were synthesized by four Schiff
base ligands 4-((4-(benzyloxy)-2-hydroxybenzylidene) amino)-[1, 1'-biphenyl]-3-ol (H 2 L 1) …
base ligands 4-((4-(benzyloxy)-2-hydroxybenzylidene) amino)-[1, 1'-biphenyl]-3-ol (H 2 L 1) …
Instigating the in vitro antidiabetic activity of new tridentate Schiff base ligand appended M (II) complexes: from synthesis, structural characterization, quantum …
In search of novel medications that could be effective in preventing and treating diabetes,
four new [Co (L)(H2O) 3](2),[Ni (L)(H2O) 3](3),[Cu (L)(H2O)](4) and [Zn (L)(H2O)](5) …
four new [Co (L)(H2O) 3](2),[Ni (L)(H2O) 3](3),[Cu (L)(H2O)](4) and [Zn (L)(H2O)](5) …
Co (II), Ni (II), Cu (II) and Zn (II) complexes of Schiff base ligands: Synthesis, characterization, DFT, in vitro antimicrobial activity and molecular docking studies
Three Schiff base ligands [H2L1–H2L3] containing nitrogen/oxygen donor atoms and their
Co (II), Ni (II), Cu (II) and Zn (II) complexes were synthesized by stirring metal acetates with …
Co (II), Ni (II), Cu (II) and Zn (II) complexes were synthesized by stirring metal acetates with …
Synthesis, characterization, single crystal structure, biological evaluation of ONO donor hydrazones and their diorganotin (IV) complexes
We have synthesized a series of four ligands (H 2 L 1-H 2 L 4) and their sixteen diorganotin
(IV) complexes R''2 SnL,[R''= Me, Et, Bu, Ph]. The ligands were derived by condensation of 2 …
(IV) complexes R''2 SnL,[R''= Me, Et, Bu, Ph]. The ligands were derived by condensation of 2 …
Metal Complexes in Target‐Specific Anticancer Therapy: Recent Trends and Challenges
Cancer is characterized by abnormal cell differentiation in or on the part of the body. The
most commonly used chemotherapeutic drugs are developed to target rapidly dividing cells …
most commonly used chemotherapeutic drugs are developed to target rapidly dividing cells …